Chris LaVictoire Mahai, Director at abrdn Healthcare Opportunities Fund (THQ), bought 568 shares at $18.49 ($11K) on 2026-07-16, disclosed to the SEC on 2026-07-20.
Director Chris LaVictoire Mahai purchased 568 shares for $10,502, marking the largest purchase of his career. This significant insider buying may signal confidence in the fund's healthcare portfolio despite the stock trading near the lower end of its 52-week range.
The stock is currently trading 12.75% below its 52-week high of $20.39 and 17.5% above its 52-week low of $15.14, with a modest 3.37% gain over the past year.
Director Chris LaVictoire Mahai executed the largest purchase of his career ($10,502) on July 16, 2026, signaling potential confidence in the fund's healthcare exposure.
The fund offers a high dividend yield of 11.53%, which may indicate elevated risk or volatility. Additionally, short interest represents 1.02% of the float, suggesting some bearish sentiment.
Nothing distinguishes this filing.
| Filing → |
| THW | BUY | 2026-07-20 | $11K | — | Filing → |
| MGU | BUY | 2006-09-27 | $10K | — | Filing → |